Bio-Techne Corp at Citi Healthcare & Medtech Conference Transcript

Mar 01, 2023 / 07:00PM GMT
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst

All right. We'll get started. Thanks, everyone, for joining us. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. I'm going to have Jim Hippel with us, CFO of Bio-Techne.

A lot to cover, but obviously, some topical news this morning just in terms of you guys closing -- or sorry, starting to close Wilson Wolf.

James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO

Yes.

Questions and Answers:

Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst

So yes, maybe just a quick update on what triggered it and your thoughts?

James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO

So as a reminder for those who may not have followed it closely, we had a deal with the owner of Wilson Wolf, John Wilson. Wilson Wolf makes the G-Rex, which is a critical component in -- we think is the future of cell and gene
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot